The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft‐versus‐host disease
From the Department of Hematology and Medical Oncology and the Department of Biostatistics, Winship Cancer Institute, the Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and the Emory University School of Public Health, Atlanta, Georgia; and the New York Blood Center, New York, New York.
From the Department of Hematology and Medical Oncology and the Department of Biostatistics, Winship Cancer Institute, the Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and the Emory University School of Public Health, Atlanta, Georgia; and the New York Blood Center, New York, New York.
From the Department of Hematology and Medical Oncology and the Department of Biostatistics, Winship Cancer Institute, the Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and the Emory University School of Public Health, Atlanta, Georgia; and the New York Blood Center, New York, New York.
From the Department of Hematology and Medical Oncology and the Department of Biostatistics, Winship Cancer Institute, the Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and the Emory University School of Public Health, Atlanta, Georgia; and the New York Blood Center, New York, New York.
From the Department of Hematology and Medical Oncology and the Department of Biostatistics, Winship Cancer Institute, the Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and the Emory University School of Public Health, Atlanta, Georgia; and the New York Blood Center, New York, New York.
From the Department of Hematology and Medical Oncology and the Department of Biostatistics, Winship Cancer Institute, the Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and the Emory University School of Public Health, Atlanta, Georgia; and the New York Blood Center, New York, New York.
From the Department of Hematology and Medical Oncology and the Department of Biostatistics, Winship Cancer Institute, the Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and the Emory University School of Public Health, Atlanta, Georgia; and the New York Blood Center, New York, New York.
From the Department of Hematology and Medical Oncology and the Department of Biostatistics, Winship Cancer Institute, the Center for Transfusion and Cellular Therapies, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, and the Emory University School of Public Health, Atlanta, Georgia; and the New York Blood Center, New York, New York.